Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Anti-CCP Antibody Levels Are Not Associated with MS: Results from a Case-Control Study.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'
Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis.
Brain functional plasticity at rest and during action in multiple sclerosis patients.
The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
Autoimmune Hepatitis with Multiple Sclerosis and Graves Disease: Coincidence or Association?
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS.
Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases.
[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
Exogenous Adult Post Mortem Neural Precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury.
Therapeutic options in neuromyelitis optica spectrum disorders.
Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis [synopsis].
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
A case of demyelinating polyneuropathy associated with anti-myelin-associated glycoprotein antibodies with progressive quadriparesis and respiratory failure.
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis.
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Pages
« first
‹ previous
…
608
609
610
611
612
613
614
615
616
…
next ›
last »